Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide

被引:208
作者
Llinas, P
Le Du, MH
Gårdsvoll, H
Dano, K
Ploug, M
Gilquin, B
Stura, EA
Ménez, A
机构
[1] CEA, Dept Ingn & Etud Prot, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France
[2] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark
关键词
cancer; structure; three-finger fold; tissue remodelling; uPAR;
D O I
10.1038/sj.emboj.7600635
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the crystal structure of a soluble form of human urokinase-type plasminogen activator receptor (uPAR/CD87), which is expressed at the invasive areas of the tumor-stromal microenvironment in many human cancers. The structure was solved at 2.7 angstrom in association with a competitive peptide inhibitor of the urokinase-type plasminogen activator (uPA)-uPAR interaction. uPAR is composed of three consecutive three-finger domains organized in an almost circular manner, which generates both a deep internal cavity where the peptide binds in a helical conformation, and a large external surface. This knowledge combined with the discovery of a convergent binding motif shared by the antagonist peptide and uPA allowed us to build a model of the human uPA-uPAR complex. This model reveals that the receptor-binding module of uPA engages the uPAR central cavity, thus leaving the external receptor surface accessible for other protein interactions (vitronectin and integrins). By this unique structural assembly, uPAR can orchestrate the fine interplay with the partners that are required to guide uPA-focalized proteolysis on the cell surface and control cell adhesion and migration.
引用
收藏
页码:1655 / 1663
页数:9
相关论文
共 60 条
[21]   Structural analysis and tissue localization of human C4.4A:: a protein homologue of the urokinase receptor [J].
Hansen, LV ;
Gårdsvoll, H ;
Nielsen, BS ;
Lund, LR ;
Dano, K ;
Jensen, ON ;
Ploug, M .
BIOCHEMICAL JOURNAL, 2004, 380 :845-857
[22]   Crystal structure of the human TβR2 ectodomain-TGF-β3 complex [J].
Hart, PJ ;
Deep, S ;
Taylor, AB ;
Shu, ZY ;
Hinck, CS ;
Hinck, AP .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (03) :203-208
[23]   INDIVIDUAL DEVELOPMENT AND UPA-RECEPTOR EXPRESSION OF DISSEMINATED TUMOR-CELLS IN BONE-MARROW - A REFERENCE TO EARLY SYSTEMIC-DISEASE IN SOLID CANCER [J].
HEISS, MM ;
ALLGAYER, H ;
GRUETZNER, KU ;
FUNKE, I ;
BABIC, R ;
JAUCH, KW ;
SCHILDBERG, FW .
NATURE MEDICINE, 1995, 1 (10) :1035-1039
[24]   Dynamics of urokinase receptor interaction with peptide antagonists studied by amide hydrogen exchange and mass spectrometry [J].
Jorgensen, TJD ;
Gårdsvoll, H ;
Dano, K ;
Roepstorff, P ;
Ploug, M .
BIOCHEMISTRY, 2004, 43 (47) :15044-15057
[25]  
Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
[26]   2 ALTERNATIVELY SPLICED MOUSE UROKINASE RECEPTOR MESSENGER-RNAS WITH DIFFERENT HISTOLOGICAL LOCALIZATION IN THE GASTROINTESTINAL-TRACT [J].
KRISTENSEN, P ;
ERIKSEN, J ;
BLASI, F ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1991, 115 (06) :1763-1771
[27]   Sequences within domain II of the urokinase receptor critical for differential ligand recognition [J].
Li, Y ;
Lawrence, A ;
Zhang, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) :29925-29932
[28]  
Lo Conte L, 1999, J MOL BIOL, V285, P2177
[29]   3 DIMENSIONAL STRUCTURE OF ERABUTOXIN-B NEUROTOXIC PROTEIN - INHIBITOR OF ACETYLCHOLINE-RECEPTOR [J].
LOW, BW ;
PRESTON, HS ;
SATO, A ;
ROSEN, LS ;
SEARL, JE ;
RUDKO, AD ;
RICHARDSON, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :2991-2994
[30]   A model for the three-dimensional structure of human plasma vitronectin from small-angle scattering measurements [J].
Lynn, GW ;
Heller, WT ;
Mayasundari, A ;
Minor, KH ;
Peterson, CB .
BIOCHEMISTRY, 2005, 44 (02) :565-574